Audicin: New Capital for Real-Time Nervous System Regulation

Audicin, a neurotechnology company based in Finland, has announced a new funding round of $1.9 million. This investment brings the company's total capital raised to approximately $3 million, solidifying its position in the development of real-time nervous system regulation tools. The round saw participation from private investors, continued support from Petteri Lahtela and Virpi Tuomivaara, and a significant contribution from Business Finland through its Deep Tech Accelerator program.

Audicin's primary goal is to integrate nervous system support into everyday environments, enabling continuous regulation without requiring dedicated user attention. This vision extends to contexts where maintaining recovery and performance is particularly critical, as demonstrated by early commercial applications.

Technology and Deployment Approach

Audicin's technology is built upon principles of brainwave entrainment, auditory engineering, and music neuroscience. These scientific foundations allow the company to develop solutions that support focus, stress recovery, productivity, and sleep. The real-time background listening sessions adapt to the user's physiological signals, facilitating continuous nervous system regulation throughout the day.

A key component of the offering is Audicin for Apps, an SDK designed to integrate real-time regulation protocols directly into digital health, performance, and consumer platforms. This SDK operates passively, activating based on biometric data, time of day, or specific in-app events. Its ability to integrate with popular wearable devices such as Oura, Apple Watch, Garmin, and Whoop, without requiring additional hardware, highlights an approach focused on local processing and efficiency.

Solutions for Sensitive Environments and Data Sovereignty

In parallel with the SDK development, Audicin is advancing a project for a standalone, offline Sleep Headband. This device is specifically designed for use in environments where mobile devices are restricted or prohibited, such as healthcare and defense settings. The Sleep Headband delivers pre-configured recovery programs based on low-frequency brainwave protocols associated with deep sleep.

The choice to develop an offline solution for sectors like defense and healthcare is particularly relevant for those concerned with infrastructure and data sovereignty. In these areas, the ability to process information locally, without relying on external cloud connections, is fundamental to ensuring privacy, security, and regulatory compliance. This approach reduces the risks associated with transmitting sensitive data and offers greater control over the infrastructure, aligning with the needs for air-gapped or self-hosted deployments.

Future Prospects and Market Impact

Audicin is already experiencing significant commercial traction across various sectors, including defense, sports performance, and wellness. The company boasts a growing pipeline of enterprise opportunities and increased user engagement following recent product updates.

The funds raised will be used for the commercialization of Audicin's core products, which include the mobile application, the Sleep Headband, and Audicin for Apps. Furthermore, the investment will support further product development and expansion into new use cases and markets. This strategic positioning, which prioritizes robust solutions capable of operating autonomously, offers an interesting model for integrating advanced technologies into contexts where resilience and local control are paramount.